Αποτελέσματα Αναζήτησης
Rexulti User Reviews & Ratings. Rexulti has an average rating of 6.6 out of 10 from a total of 445 reviews on Drugs.com. 54% of reviewers reported a positive experience, while 26% reported a negative experience.
Find 111 user ratings and reviews for Rexulti (brexpiprazole) on WebMD including side effects and drug interactions, medication effectiveness, ease of use and satisfaction.
27 Ιουν 2024 · Rexulti is a third-generation antipsychotic medicine that works by increasing dopamine and serotonin levels in the brain. It may improve mood and behavior by blocking certain receptors in the...
18 Μαΐ 2023 · Rexulti (brexpiprazole) is a once-daily oral therapy that is approved to help manage agitation — abnormal or inappropriate displays of emotion, such as shouting or shoving — associated with dementia due to Alzheimer’s disease. It was co-developed by Otsuka Pharmaceutical and Lundbeck.
12 Μαΐ 2023 · The U.S. Food and Drug Administration (FDA) this week approved the expanded use of Rexulti (brexpiprazole) for the treatment of agitation associated with dementia due to Alzheimer’s disease (AD).
16 Μαΐ 2023 · The Food and Drug Administration (FDA) last week approved Rexulti (brexpiprazole) for treating agitation in Alzheimer’s patients. This is the first-ever treatment option for dementia-associated agitation.
SIGNIFICANT reduction in frequency of agitation symptoms. Studied in two 12-week clinical trials with patients aged 51-90 diagnosed with agitation that may happen with dementia due to Alzheimer's disease. Individual results may vary.
